Abdominal obesity, specifically visceral adipose tissue (VAT), is associated with a greater risk of developing T2DM than peripheral obesity because expanded visceral fat stores affect insulin metabolism by releasing free fatty acids into the portal circulation, which may reduce the hepatic clearance of insulin, thus leading to IR and hyperinsulinemia (8). Here, INS is linked to Abdominal obesity.